Search research articles
Contact Us
Filters
Showing results (91-100 of 173) with videos related to
Page
of 18
Sort By:
Brain Research
|
November 17, 2009
Expression of G protein-coupled receptor 30 in the spinal somatosensory system
Keiko Takanami, Hirotaka Sakamoto, Ken-Ichi Matsuda, et al.
International Journal of Surgical Pathology
|
June 3, 2011
Mesothelin and GPR30 staining among a spectrum of pancreatic epithelial neoplasms
Joseph P Glass, Gulshan Parasher, Hugo Arias-Pulido, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 28, 2024
GPER expression prevents estrogen-induced urinary retention in obese mice
Donna F Kusewitt, Geetanjali Sharma, Christine D Woods, et al.
Advances in Protein Chemistry
|
September 15, 2007
Some mechanistic insights into GPCR activation from detergent-solubilized ternary complexes on beads
Tione Buranda, Anna Waller, Yang Wu, et al.
Journal of Biomolecular Screening
|
June 21, 2005
High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands
Susan M Young, Cristian Bologa, Eric R Prossnitz, et al.
Endocrinology
|
September 18, 2007
Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei
Hirotaka Sakamoto, Ken-ichi Matsuda, Koji Hosokawa, et al.
Trends in Pharmacological Sciences
|
November 9, 2004
Techniques: GPCR assembly, pharmacology and screening by flow cytometry
Anna Waller, Peter C Simons, Sean M Biggs, et al.
Molecular Cancer Research : MCR
|
July 18, 2014
GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding
Tapan K Nayak, Chinnasamy Ramesh, Helen J Hathaway, et al.
Nature Protocols
|
April 5, 2007
Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform
Bruce S Edwards, Susan M Young, Tudor I Oprea, et al.
Drug Discovery Today. Technologies
|
April 15, 2024
Integration of virtual and physical screening
Dan C Fara, Tudor I Oprea, Eric R Prossnitz, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 173) with videos related to
Sort By:
Page
of 18
Brain Research
|
November 17, 2009
Expression of G protein-coupled receptor 30 in the spinal somatosensory system
Keiko Takanami, Hirotaka Sakamoto, Ken-Ichi Matsuda, et al.
International Journal of Surgical Pathology
|
June 3, 2011
Mesothelin and GPR30 staining among a spectrum of pancreatic epithelial neoplasms
Joseph P Glass, Gulshan Parasher, Hugo Arias-Pulido, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 28, 2024
GPER expression prevents estrogen-induced urinary retention in obese mice
Donna F Kusewitt, Geetanjali Sharma, Christine D Woods, et al.
Advances in Protein Chemistry
|
September 15, 2007
Some mechanistic insights into GPCR activation from detergent-solubilized ternary complexes on beads
Tione Buranda, Anna Waller, Yang Wu, et al.
Journal of Biomolecular Screening
|
June 21, 2005
High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands
Susan M Young, Cristian Bologa, Eric R Prossnitz, et al.
Endocrinology
|
September 18, 2007
Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei
Hirotaka Sakamoto, Ken-ichi Matsuda, Koji Hosokawa, et al.
Trends in Pharmacological Sciences
|
November 9, 2004
Techniques: GPCR assembly, pharmacology and screening by flow cytometry
Anna Waller, Peter C Simons, Sean M Biggs, et al.
Molecular Cancer Research : MCR
|
July 18, 2014
GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding
Tapan K Nayak, Chinnasamy Ramesh, Helen J Hathaway, et al.
Nature Protocols
|
April 5, 2007
Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform
Bruce S Edwards, Susan M Young, Tudor I Oprea, et al.
Drug Discovery Today. Technologies
|
April 15, 2024
Integration of virtual and physical screening
Dan C Fara, Tudor I Oprea, Eric R Prossnitz, et al.
Page
of 18